GLIOMATCH results contribute to new EIC-funded project GLIOBREAK
On International Childhood Cancer Day, GLIOMATCH highlights the urgent need for research into paediatric high-grade gliomas (pHGGs), rare and aggressive brain tumours affecting children. With a median survival of just over one year and no curative treatment available, collaborative research efforts are essential to better understand the disease, develop dedicated models, and tailor therapies that improve outcomes and quality of life for young patients and their families.
International Childhood Cancer Day 2026
On International Childhood Cancer Day, GLIOMATCH highlights the urgent need for research into paediatric high-grade gliomas (pHGGs), rare and aggressive brain tumours affecting children. With a median survival of just over one year and no curative treatment available, collaborative research efforts are essential to better understand the disease, develop dedicated models, and tailor therapies that improve outcomes and quality of life for young patients and their families.
International Day of Women and Girls in Science 2026
GLIOMATCH celebrates the women researchers across its consortium whose expertise and commitment drive the development of tailored immunotherapies for malignant brain tumours, marking the International Day of Women and Girls in Science 2026.
World Cancer Day 2026
On World Cancer Day 2026, GLIOMATCH highlights the importance of placing patient perspectives at the heart of cancer research, particularly for glioblastoma, one of the most aggressive and difficult-to-treat brain tumours.
GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany
From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.
International Day of Women and Girls in Science 2025
On the 10th anniversary of the International Day of Women and Girls in Science, GLIOMATCH celebrates the women driving our research and our commitment to gender balance in science and leadership.
World Cancer Day 2025
On World Cancer Day 2025, the GLIOMATCH project participated in the EU project showcase hosted by HaDEA, highlighting the role of EU-funded research in advancing cancer care. We have seized this opportunity to map the EU Cancer Mission project landscape.
GLIOMATCH Receives Ethical Approval for Retrospective Clinical Trials
The GLIOMATCH project has received ethical approval from the UZ/KU Leuven Ethics Committee to conduct retrospective clinical trials for adult and paediatric glioma patients. This follows earlier approvals for other project partners, setting data collection to begin in 2025,.
Spatial proteomics named 2024 Method of the Year by Nature Methods
Spatial proteomics, a technique which maps protein distributions within tissues with high resolution, is central to the GLIOMATCH project.
European Cancer Summit 2024
GLIOMATCH was featured at the European Cancer Summit 2024, held on 20–21 November in Brussels and online. We’re proud to support Europe’s fight against cancer.